SIGA Technologies
SIGA
#7361
Rank
NZ$0.76 B
Marketcap
NZ$10.73
Share price
-2.21%
Change (1 day)
4.52%
Change (1 year)

Earnings for SIGA Technologies (SIGA)

Earnings in 2025 (TTM): NZ$0.15 Billion

According to SIGA Technologies's latest financial reports the company's current earnings are NZ$0.17 Billion. In 2024 the company made an earning of NZ$0.12 Billion a decrease over its 2023 earnings that were of NZ$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SIGA Technologies from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.15 B27.61%
2024 NZ$0.12 B-16.31%
2023 NZ$0.14 B89.48%
2022 NZ$76.39 M-50.38%
2021 NZ$0.15 B16.22%
2020 NZ$0.13 B1268.64%
2019 NZ$9.67 M-98.69%
2018 NZ$0.73 B-1912.24%
2017 -NZ$40.8 Million-7.91%
2016 -NZ$44.31 Million-30.38%
2015 -NZ$63.64 Million-82.62%
2014 -NZ$0.37 Billion796.54%
2013 -NZ$40.84 Million5.18%
2012 -NZ$38.83 Million-28.53%
2011 -NZ$54.33 Million
2009 -NZ$20.57 Million35.95%
2008 -NZ$15.13 Million17.07%
2007 -NZ$12.92 Million9.58%
2006 -NZ$11.79 Million168.94%
2005 -NZ$4.39 Million-71.48%
2004 -NZ$15.38 Million67.71%
2003 -NZ$9.17 Million57.35%
2002 -NZ$5.83 Million3.73%
2001 -NZ$5.62 Million-54.2%
2000 -NZ$12.27 Million105.09%
1999 -NZ$5.98 Million-33.58%
1998 -NZ$9.01 Million477.78%
1997 -NZ$1.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Emergent BioSolutions
EBS
NZ$0.28 B 83.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion-383.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.64 B 315.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$16.39 Million-110.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.46 Million-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-NZ$0.44 Billion-379.31%๐Ÿ‡บ๐Ÿ‡ธ USA